Bioventus Inc
NASDAQ:BVS
Bioventus Inc
Cash from Financing Activities
Bioventus Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Bioventus Inc
NASDAQ:BVS
|
Cash from Financing Activities
$62.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$307m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$13.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
See Also
What is Bioventus Inc's Cash from Financing Activities?
Cash from Financing Activities
62.1m
USD
Based on the financial report for Dec 31, 2022, Bioventus Inc's Cash from Financing Activities amounts to 62.1m USD.
What is Bioventus Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
15%
Over the last year, the Cash from Financing Activities growth was -77%.